Regulation of lymphocyte proliferation and death by flip

Nature Reviews Immunology

Volumn 1, Issue 1, 2001, Pages 50-58

  Thome, Margot ^a   Tschopp, Jürg ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; CFLAR PROTEIN, HUMAN; FAS ANTIGEN; FLICE INHIBITORY PROTEIN; SIGNAL PEPTIDE;

ANIMAL; APOPTOSIS; AUTOIMMUNE DISEASE; BIOLOGICAL MODEL; CELL DIVISION; CHEMISTRY; CYTOLOGY; GENETICS; HUMAN; IMMUNOLOGY; LEUKOCYTE; LYMPHOCYTE; LYMPHOCYTE ACTIVATION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; AUTOIMMUNE DISEASES; CARRIER PROTEINS; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; CELL DIVISION; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LEUKOCYTES; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; MODELS, IMMUNOLOGICAL; SIGNAL TRANSDUCTION;

EID: 0035496099     PISSN: 14741733     EISSN: None     Source Type: Journal    
DOI: 10.1038/35095508     Document Type: Review

References (89)

1. Kerr, J., Wyllie, A. H. & Currie, A. R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Brit. J. Cancer 68, 239-257 (1972). One of the first descriptions of the nature and consequences of apoptotic cell death.
2. Fiers, W., Beyaert, R., Declercq, W. & Vandenabeele, P. More than one way to die: apoptosis, necrosis and reactive oxygen damage. Oncogene 18, 7719-7730 (1999).
3. Holler, N. et al. Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nature Immunol. 1, 489-495 (2000).
4. Nicholson, D. W. Caspase structure, proteolytic substrates, and function during apoptotic cell death. Cell Death Offer. 6, 1028-1042 (1999).
5. Ashkenazi, A. & Dixit, V. M. Apoptosis control by death and decoy receptors. Curr. Opin. Cell Biol. 11, 255-260 (1999).
6. Green, D. R. & Reed, J. C. Mitochondria and apoptosis. Science 281, 1309-1312 (1998).
7. Hofmann, K. The modular nature of apoptotic signaling proteins. Cell. Mol. Life Sci. 55, 1113-1128 (1999). Excellent review on the role of the death-domain-fold motifs in apoptotic signalling pathways.
8. Locksley, R. M., Killeen, N. & Lenardo, M. J. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 104, 487-501 (2001). Most recent review on the biology of the tumour-necrosis-factor family members.
9. Adams, J. M. & Cory, S. Life-or-death decisions by the Bcl-2 protein family. Trends Biochem. Sci. 26, 61-66 (2001).
10. Deveraux, O. L. & Reed, J. C. IAP family proteins - suppressors of apoptosis. Genes Dev. 13, 239-252 (1999).
11. Hu, S., Vincenz, C., Buller, M. & Dixit, V. M. A novel family of viral death effector domain-containing molecules that inhibit both CD-95- and tumor necrosis factor receptor-1-induced apoptosis. J. Biol. Chem. 272, 9621-9624 (1997).
12. Berlin, J. et al. Death effector domain-containing herpesvirus and poxvirus proteins inhibit both Fas- and TNFR1-induced apoptosis. Proc. Natl Acad. Sci. USA 94, 1172-1176 (1997).
13. Thome, M. et al. Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature 386, 517-521 (1997).
14. Searles, R. P., Bergquam, E. P., Axthelm, M. K. & Wong, S. W. Sequence and genomic analysis of a Rhesus macaque rhadinovirus with similarity to Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8. J. Virol. 73, 3040-3053 (1999).
15. Irmler, M. et al. Inhibition of death receptor signals by cellular FLIP. Nature 388, 190-195 (1997).
16. Shu, H. B., Halpin, D. R. & Goeddel, D. V. Casper is a FADD- and caspase-related inducer of apoptosis. Immunity 6, 751-763 (1997).
17. Srinivasula, S. M. et al. FLAME-1, a novel FADD-like anti-apoptotic molecule that regulates Fas/TNFR1-induced apoptosis. J. Biol. Chem. 272, 18542-18545 (1997).
18. Inohara, N., Koseki, T., Hu, Y., Chen, S. & Nunez, G. CLARR a death effector domain-containing protein interacts with caspase-8 and regulates apoptosis. Proc. Natl Acad. Sci. USA 94, 10717-10722 (1997).
19. Goltsev, Y. V. et al. CASH, a novel caspase homologue with death effector domains. J. Biol. Chem. 272, 19641-19644 (1997).
20. L and initiates cell death. Proc. Natl Acad. Sci. USA 94, 11333-11338 (1997).
21. Hu, S., Vincenz, C., M. J., Gentz, R. & Dixit, V. M. I-FLICE, a novel inhibitor of tumor necrosis factor receptor-1- and CD-95-induced apoptosis. J. Biol. Chem. 272, 17255-17257 (1997).
22. Rasper, D. M. et al. Cell death attenuation by 'Usurpin', a mammalian DED-caspase homologue that precludes caspase-8 recruitment and activation by the CD-95 (Fas, AFO-1) receptor complex. Cell Death Differ. 5, 271-288 (1998).
23. Cohen, G. M. Caspases: the executioners of apoptosis. Biochem. J. 326, 1-16 (1997).
24. Scaffidi, C., Schmitz, I., Krammer, P. H. & Peter, M. E. The role of c-FLIP in modulation of CD95-induced apoptosis. J. Biol. Chem. 274, 1541-1548 (1999).
25. Yeh, W. C. et al. Requirement for Casper (c-FLIP) in regulation of death receptor-induced apoptosis and embryonic development. Immunity 12, 633-642 (2000).
26. Siegel, R. M., Chan, F. K., Chun, H. J. & Lenardo, M. J. The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunity. Nature Immunol. 1, 469-474 (2000).
27. Krammer, P. H. CD95's deadly mission in the immune system. Nature 407, 789-795 (2000).
28. Krueger, A., Schmitz, I., Baumann, S., Krammer, P. H. & Kirchhoff, S. Cellular FLICE-inhibitory protein splice variants inhibit different steps of caspase-8 activation at the CD95 death-inducing signaling complex. J. Biol. Chem. 276, 20633-20640 (2001).
29. Schneider, P. et al. TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-κB. Immunity 7, 831-835 (1997).
30. Kataoka, T. et al. The caspase-8 inhibitor FLIP promotes activation of NF-κB and Erk signaling pathways. Curr. Biol. 10, 640-648 (2000).
31. Hu, W. H., Johnson, H. & Shu, H. B. Activation of NF-κB by FADD, Casper, and caspase-8. J. Biol. Chem. 275, 10838-10844 (2000).
32. Chaudhary, P. M., Jasmin, A., Eby, M. T. & Hood, L. Modulation of the NF-κB pathway by virally encoded death effector domains-containing proteins. Oncogens 18, 5738-5746 (1999).
33. Chaudhary, P. M. et al. Activation of the NF-κB pathway by caspase 8 and its homologs. Oncogene 19, 4451-4460 (2000).
34. Inohara, N., del Peso, L. Koseki, T., Chen, S. & Nunez, G. RICK, a novel protein kinase containing a caspase recruitment domain, interacts with CLARP and regulates CD95-mediated apoptosis. J. Biol. Chem. 273, 12296-12300 (1998).
35. Kneitz, B,. Herrmann, T., Yonehara, S. & Schimpl, A. Normal clonal expansion but impaired Fas-mediated cell death and anergy induction in interieukin-2-deficient mice. Eur. J. Immunol. 25, 2572-2577 (1995).
36. Lenardo, M. J. Interleukin-2 programs mouse αβ T lymphocytes for apoptosis. Nature 353, 858-861 (1991). First report on the requirement of interieukin-2 for activation-induced cell death.
37. Zheng, L. et al. Induction of apoptosis in mature T cells by tumour necrosis factor. Nature 377, 348-351 (1995).
38. Spaner, D., Raju, K., Rabinovich, B. & Miller, R. G. A role for perforin in activation-induced T cell death in vivo: increased expansion of allogeneic perforin-deficient T cells in SCID mice. J. Immunol. 162, 1192-1199 (1999).
39. Hildeman, D. A. et al. Reactive oxygen species regulate activation-induced T cell apoptosis. Immunity 10, 735-744 (1999).
40. Algeciras-Schimnich, A., Griffith, T. S., Lynch, D. H. & Paya, C. V. Cell cycle-dependent regulation of FLIP levels and susceptibility to Fas-mediated apoptosis. J. Immunol. 162, 5205-5211 (1999).
41. Refaeli, Y., Van Parijs, L., London, C. A., Tschopp, J. & Abbas, A. K. Biochemical mechanisms of IL-2-regulated Fas-mediated T cell apoptosis. Immunity 8, 615-623 (1998).
42. Van Parijs, L. Refaeli, Y., Abbas, A. K. & Baltimore, D. Autoimmunity as a consequence of retrovirus-mediated expression of c-FLIP in lymphocytes. Immunity 11, 763-770 (1999).
43. Yeh, J. H., Hsu, S. C., Han, S. H. & Lai, M. Z. Mitogen-activated protein kinase kinase antagonized as-associated death domain protein-mediated apoptosis by induced FLICE-inhibitory protein expression. J. Exp. Med. 188, 1795-1802 (1998).
44. Inaba, M. et al. Primed T cells are more resistant to Fas-mediated activation-induced cell death than naive T cells. J. Immunol. 163, 1315-1320 (1999).
45. Kirchhoff, S., Muller, W. W., Krueger, A., Schmitz, I. & Krammer, P. H. TCR-mediated up-regulation of c-FLIP(short) correlates with resistance toward CD95-mediated apoptosis by blocking death-inducing signaling complex activity. J. Immunol. 165, 6293-6300 (2000).
46. Semra, Y. K., Seidi, O. A. & Sharief, M. K. Overexpression of the apoptosis inhibitor FLIP in T cells correlates with disease activity in multiple sclerosis. J. Neuroimmunol. 113, 268-274 (2001).
47. Smith, K. G., Strasser, A. & Vaux, D. L. CrmA expression in T lymphocytes of transgenic mice inhibits CD95 (Fas/APO-1)-transduced apoptosis, but does not cause lymphadenopathy or autoimmune disease. EMBO J. 15, 5167-5176 (1996).
48. Newton, K., Harris, A. W., Bath, M. L., Smith, K. G. C. & Strasser, A. A dominant interfering mutant of FADD/MORT1 enhances deletion of autoreactive thymocytes and inhibits proliferation of mature T lymphocytes. EMBO J. 17, 706-718 (1998).
49. Walsh, C. M. et al. A role for FADD in T cell activation and development. Immunity 8, 439-449 (1998).
50. Strasser, A, Harris, A. W., Huang, D. C., Krammer, P. H. & Cory, S. Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis. EMBO J. 14, 6136-6147 (1995).
51. Bouillet, P. et al. Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science 286, 1735-1738 (1999).
52. Micheau, O., Lens, S., Gaide, O., Alevizopoulos, K. & Tschopp, J. NF-κ signals induce the expression of c-FLIP. Mol. Cell. Biol. 21, 5299-5305 (2001).
53. Kreuz, S., Siegmund, D., Scheurich, P. & Wajant, H. NF-κB inducers upregulate cFLIP, a cycloheximide-sensitive inhibitor of death receptor signaling. Mol. Cell. Biol. 21, 3964-3973 (2001).
54. Zhang, J., Cado, D., Chen, A, Kabra, N. H. & Winoto, A. Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1. Nature 392, 296-300 (1998).
55. Newton, K., Harris, A. W. & Strasser, A. FADD/MORT1 regulates the pre-TCR checkpoint and can function as a tumour suppressor. EMBO J. 19, 931-941 (2000).
56. OhYama, T., Tsukumo, S., Yajima, N., Sakamaki, K. & Yonehara, S. Reduction of thymocyte numbers in transgenic mice expressing viral FLICE-inhibitory protein in a Fas-independent manner. Microbiol. Immunol. 44, 289-297 (2000).
57. Alderson, M. R. et al. Fas transduces activation signals in normal human T lymphocytes. J. Exp. Med. 178, 2231-2235 (1993).
58. Alderson, M. R. et al. Regulation of apoptosis and T cell activation by Fas-specific mAb. Int. Immunol. 6, 1799-1806 (1994).
59. Kennedy, N. J., Kateoka, T., Tschopp, J. & Budd, R. C. Caspase activation is required for T cell proliferation. J. Exp. Med. 190, 1891-1896 (1999).
60. Alam, A., Cohen, L. Y., Aouad, S. & Sekaly, R. P. Early activation of caspases during T lymphocyte stimulation results in selective substrate cleavage in nonapoptotic cells. J. Exp. Med. 190, 1879-1890 (1999).
61. Zornig, M., Hueber, A. O. & Evan, G. p53-dependent impairment of T-cell proliferation in FADD dominant-negative transgenic mice. Curr. Biol. 8, 467-470 (1998).
62. Rathmell, J. C., Townsend, S. E., Xu, J. C., Raven, R. A. & Goodnow, C. C. Expansion or elimination of B cells in vivo: dual roles for CD40- and Fas (CD95)-ligands modulated by the B cell antigen receptor. Cell 87, 319-329 (1996).
63. Wang, J. et al. Inhibition of Fas-mediated apoptosis by the B cell antigen receptor through C-FLIP. Eur. J. Immunol. 30, 155-163 (2000).
64. Hennino, A., Berard, M., Casamayor-Palleja, M., Krammer, P. H. & Defrance, T. Regulation of the Fas death pathway by FLICE-inhibitory protein in primary human B cells. J. Immunol. 165, 3023-3030 (2000).
65. Nagata, S. Apoptosis by death factor. Cell 88, 355-365 (1997).
66. Kiener, P. A. et al. Differential induction of apoptosis by Fas-Fas ligand interactions in human monocytes and macrophages. J. Exp. Med. 185, 1511-1516 (1997).
67. Perlman, H. et al. FLICE-inhibitory protein expression during macrophage differentiation confers resistance to fas-mediated apoptosis. J. Exp. Med. 190, 1679-1688 (1999).
68. L and resistance to CD95-mediated apoptosis of monocyte-derived dendritic cells: inhibition by bisindolylmaleimide. Blood 95, 3478-3482 (2000).
69. Rescigno, M. et al. Fas engagement induces the maturation of dendritic cells (DCs), the release of interieukin (IL)-1β, and the production of Interferon γ in the absence of IL-12 during DC-T cell cognate interaction: a new role for Fas ligand in inflammatory responses. J. Exp. Med. 192, 1661-1668 (2000).
70. Conlon, P., Oksenberg, J. R., Zhang, J. & Steinman, L. The immunobiology of multiple sclerosis: an autoimmune disease of the central nervous system. Neurobiol. Dis. 6, 149-166 (1999).
71. Sharief, M. K. Increased cellular expression of the caspase inhibitor FLIP in intrathecal lymphocytes from patients with multiple sclerosis. J. Neuroimmunol. 111, 203-209 (2000).
72. Stassi, G. et al. Control of target cell survival in thyroid autoimmunity by T helper cytokines via regulation of apoptotic proteins. Nature Immunol. 1, 483-488 (2000).
73. Yeh, W. C. et al. FADD: essential for embryo development and signaling from some, but not all, inducers of apoptosis. Science 279, 1954-1958 (1998).
74. Vartolomeev, E. E. et al. Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally. Immunity 9, 267-276 (1998).
75. Yeh, W. C., Hakem, R., Woo, M. & Mak, T. W. Gene targeting in the analysis of mammalian apoptosis and TNF receptor superfamily signaling. Immunol. Rev. 169, 283-302 (1999).
76. Imanishi, T. et al. Cellular FLIP is expressed in cardiomyocytes and down-regulated in TUNEL-positive grafted cardiac tissues. Cardiovasc. Res. 48, 101-110 (2000).
77. Imanishi, T. et al. Expression of cellular FLICE-inhibitory protein in human coronary arteries and in a rat vascular injury model. Am. J. Pathol. 156, 125-137 (2000).
78. Sata, M. & Walsh, K. Endothelial cell apoptosis induced by oxidized LDL is associated with the down-regulation of the cellular caspase inhibitor FLIP. J. Biol. Chem. 273, 33103-33106 (1998).
79. Mueller, C. M. & Scott, D. W. Distinct molecular mechanisms of Fas resistance in murine B lymphoma cells. J. Immunol. 165, 1854-1862 (2000).
80. Tepper, C. G. & Seldin, M. F. Modulation of caspase-8 and FLICE-inhibitory protein expression as a potential mechanism of Epstein-Barr virus tumorigenesis in Burkitt's lymphoma. Blood 94, 1727-1737 (1999).
81. Irisarri, M. et al. Resistance to CD95-mediated apoptosis through constitutive C-FLIP expression in a non-Hodgkin's lymphoma B cell line. Leukemia 14, 2149-2158 (2000).
82. French, L. E. & Tschopp, J. Inhibition of death receptor signaling by FLICE-inhibitory protein as a mechanism for immune escape of tumors. J. Exp. Med. 190, 891-894 (1999).
83. Djerbi, M. et al. The inhibitor of death receptor signaling, FLICE-inhibitory protein defines a new class of tumor progression factors. J. Exp. Med. 190, 1025-1032 (1999).
84. Medema, J. P., de Jong, J., van Hall, T., Melief, C. J. & Offringa, R. Immune escape of tumors in vivo by expression of cellular FLICE-inhibitory protein. J. Exp. Med. 190, 1033-1038 (1999).
85. Ugurel, S. et al. Heterogenous susceptibility to CD95-induced apoptosis in melanoma cells correlates with bcl-2 and bcl-x expression and is sensitive to modulation by interferon-γ. Int. J. Cancer 82, 727-736 (1999).
86. Raisova, M. etal. Resistance to CD95/Fas-induced and ceramide-mediated apoptosis of human melanoma cells is caused by a defective mitochondrial cytochrome c release. FEBS Lett 473, 27-32 (2000).
87. Griffith, T. S., Chin, W. A., Jackson, G. C., Lynch, D. H. & Kubin, M. Z. Intracellular regulation of TRAIL-induced apoptosis in human melanoma cells. J. Immunol. 161, 2833-2840 (1998).
88. Zhang, X. D. et al. Relation of TNF-related apoptosis-inducing ligand (TRAIL) receptor and FLICE-inhibitory protein expression to TRAIL-induced apoptosis of melanoma. Cancer Res. 59, 2747-2753 (1999).
89. Adams, J. M. & Cory, S. The Bcl-2 protein family: arbiters of cell survival. Science 281, 1322-1326 (1998).